New guidelines issued for occupational exposures.
D019380:Anti-HIV Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy / Q000517:prevention & control*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use; D006282:Health Personnel; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use; D016273:Occupational Exposure; D017410:Practice Guidelines as Topic; D014481:United States; D014492:United States Public Health Service; D015215:Zidovudine / Q000627:therapeutic use
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D019259:Lamivudine; D015215:Zidovudine